Filed before 2025Filed 27 November 2023
Eikonoklastes Therapeutics, Inc. raised $2M
Eikonoklastes Therapeutics, Inc., a pharmaceuticals company based in Cincinnati, OH, raised $2M in a new debt round, according to a filing dated 27 November 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 27 November 2023
- Round
- Debt round
- Amount sold
- $2M
- Offering size
- $15M
- Investors so far
- 1
- Based in
- Cincinnati, OH
- Website
- eikonoklastes.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 21% of the 1,396 tracked raises with an amount filed in 2023.
Eikonoklastes Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 29 Jul 2025 | New filing | $13.6M | Another raise |
| 25 Jun 2024 | New filing | $2.4M | Another raise |
| 27 Nov 2023 | New filing | $2M | This raise |
| 13 Jan 2022 | New filing | $2.8M | Another raise |
| 6 May 2021 | New filing | $3.18M | Another raise |
More with Aceso Interests on the board
- My Diabetes Health, Inc.$4.46M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.